Wasatch Advisors Inc Bristol Myers Squibb CO Transaction History

Wasatch Advisors Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $238,481 - $313,965	-5,925 Reduced 6.78%	81,450 $3.38 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $169,680 - $202,475	3,500 Added 4.17%	87,375 $4.48 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $376,285 - $420,745	6,500 Added 8.4%	83,875 $4.87 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $254,840 - $282,960	4,000 Added 5.45%	77,375 $4.95 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $657,099 - $745,300	10,000 Added 15.78%	73,375 $5.09 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $273,920 - $324,360	-4,000 Reduced 5.94%	63,375 $4.56 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $290,480 - $319,920	4,000 Added 6.31%	67,375 $5.19 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $491,840 - $589,760	8,000 Added 14.45%	63,375 $4.63 Million
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $214,520 - $250,080	4,000 Added 7.79%	55,375 $3.45 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $5,147 - $6,029	-87 Reduced 0.17%	51,375 $3.04 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $3.19 Million - $3.47 Million	51,462 New	51,462 $3.44 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.